JW Shinyak Corporation logo

JW Shinyak Corporation (067290)

Market Closed
11 Aug, 06:30
KRX SM KRX SM
2,280. 00
+55
+2.4719%
75.22B Market Cap
- P/E Ratio
120% Div Yield
9.29M Volume
- Eps
2,225
Previous Close
Add Transaction
Day Range
2,215 2,420
Year Range
1,246 3,465
Want to track 067290 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

067290 closed today higher at ₩2,280, an increase of 2.4719% from yesterday's close, completing a monthly increase of 21.5352% or ₩404. Over the past 12 months, 067290 stock gained 6.7916%.
067290 pays dividends to its shareholders, with the most recent payment made on Jan 05, 2021.
JW Shinyak Corporation has completed 11 stock splits, with the recent split occurring on Dec 30, 2025.
The company's stock is traded on one exchange.

067290 Chart

People also search for

Fine M-Tec Co., Ltd.
8,930
-2.5109%
Genexine Co., Ltd.
2,755
+1.2868%
TiumBio Co., Ltd.
4,950
-1.5905%
GeneOne Life Science Inc.
2,670
0%
Iljin Diamond Co. Ltd.
9,160
0%

JW Shinyak Corporation (067290) FAQ

What is the stock price today?

The current price is ₩2,280.00.

On which exchange is it traded?

JW Shinyak Corporation is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 067290.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 120%.

What is its market cap?

As of today, the market cap is 75.22B.

Has JW Shinyak Corporation ever had a stock split?

JW Shinyak Corporation had 11 splits and the recent split was on Dec 30, 2025.

JW Shinyak Corporation Profile

Health Care Providers & Services Industry
Healthcare Sector
- CEO
KRX SM Exchange
- ISIN
South Korea Country
- Employees
- Last Dividend
30 Dec 2025 Last Split
- IPO Date

Overview

JW Shinyak Corporation stands as a distinguished entity in the pharmaceutical industry, focusing primarily on the innovation, manufacturing, and distribution of healthcare products. With its firm foundations in South Korea, the company extends its reach globally, making significant contributions to the biotech and healthcare sectors. By concentrating on prescription medications, over-the-counter remedies, and therapeutic treatments, JW Shinyak addresses critical therapeutic areas such as cardiovascular diseases, oncology, and central nervous system disorders. Through its dedication to advancing medical research and enhancing patient outcomes, JW Shinyak plays a crucial role in improving access to quality healthcare solutions worldwide. The company’s commitment extends beyond product development to include continuous research efforts and strategic collaborations aimed at pushing the boundaries of medical science and healthcare delivery.

Products and Services

  • Prescription Drugs

    JW Shinyak specializes in developing a wide range of prescription medications designed to meet the diverse needs of patients across various therapeutic areas. These drugs undergo rigorous testing and quality control to ensure efficacy and safety for treating conditions such as cardiovascular diseases, cancer, and neurological disorders. By focusing on these critical areas, JW Shinyak provides essential medications that contribute significantly to the well-being of patients worldwide.

  • Over-the-Counter Medicines

    In addition to prescription medications, JW Shinyak offers an array of over-the-counter (OTC) medicines. These products cater to everyday health needs, allowing individuals to access treatment for minor ailments without the need for a prescription. From pain relief to cold and allergy remedies, JW Shinyak’s OTC portfolio supports overall health and wellness, making quality healthcare more accessible to the public.

  • Therapeutic Treatments

    Building on its extensive pharmaceutical expertise, JW Shinyak also develops therapeutic treatments targeted at specific diseases and conditions. These treatments are the result of cutting-edge research and innovation, aimed at providing advanced options for managing complex health issues. Through targeted therapies, JW Shinyak aims to improve patient outcomes, especially in challenging areas like oncology and central nervous system disorders, offering hope and enhanced quality of life to those affected.

Contact Information

Address: -
Phone: -